IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable ...
Aris Mining is positioned for multi-year profitable growth, targeting 1 Mozpa production by 2031—over 4x its current ...
A phase 1/2 clinical trial examining the CRISPR-engineered allogeneic chimeric antigen receptor (CAR)-T candidate AVC-203 (QUADvance) has been approved by the FDA and the European Medicines Agency ...
Tucatinib addition to trastuzumab and pertuzumab significantly improved PFS in HER2-positive metastatic breast cancer, with a median PFS of 24.9 months versus 16.3 months with placebo. The PFS benefit ...
The Broncos have been dealing with a salary cap crunch for the past couple of seasons. They’ve handed expensive deals to Pat ...
Established in 2018 by a resident of the area, Mrs Oluwatosin Adeniyi, this makeshift school offers free education with sets ...
Highlights: Significant mineralized sections were intercepted in N2-25-006, N2-25-009 and N2-25-011 drilled in the "A" zone, ...
From Allegation to Prosecution: The Military Case Against Maj. Blaine McGraw ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback